GlassScriptPhysician profile
Pankaj Garg
NPI 1629082763
$4,352.42
in general payments reported to CMS, 2019-2025
43 companies · $592 in 2025
The $592 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $517 · 2021: $973 · 2022: $662 · 2023: $409 · 2024: $326 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764 · Travel and Lodging: $530 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.35 |
| Travel and Lodging | $530.42 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $536.66 | 2025 | |
| Abbvie INC. | $457.89 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $366.02 | 2019-2023 | Ajovy |
| Amgen INC. | $356.96 | 2019-2024 | Aimovig |
| Lilly USA, LLC | $294.67 | 2019-2025 | Emgality, Reyvow, Zepbound |
| Pacira Therapeutics, INC. | $286.77 | 2019-2020 | |
| Abbott Laboratories | $197.95 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $169.97 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $137.48 | 2024 | Spravato |
| Eisai INC. | $128.50 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $122.98 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $119.12 | 2021 | |
| Biodelivery Sciences International, INC. | $109.65 | 2019-2020 | |
| Orexo US, INC. | $101.08 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $91.58 | 2023 | Optimizer |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pankaj Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.